NEWSROOM

Stox Media – Wall Street Nation

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Aug 12, 2024

Top Line Data Expected Year-End 2024 Pittsburgh, August 12, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” “we” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces the dosing of the first two patients with LP-310 in its Phase 2a clinical trial in Oral Lichen Planus (OLP) patients. Lipella’s Phase 2a trial is a multicenter, dose-ranging study involving adult male and female subjects...

ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides

ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides

Aug 9, 2024

Melanocortin receptors on neurons in the brain control feeding and weight loss Patented peptide molecules delivered orally as a pill can control feeding disorders and weight loss NEW YORK, NY, August 09, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA) has announced that, as a result of its worldwide licensing agreement with Teleost Biopharmaceuticals and the University of Arizona, it plans to pursue the development of therapeutics using novel proprietary peptides that selectively bind and activate...

Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results

Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results

Aug 8, 2024

Interest in kidney transplant assay represents approximately 25% of US transplant volume Company lays out land and expand strategy in transplant IRVINE, Calif., August 8, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published its second quarter 2024 results and the following letter to shareholders. Dear shareholders, We are thrilled to report that we have successfully launched GraftAssureTM, which is our research-use-only assay that can detect...

Premier Graphene President Pedro Mendez Meets with Global Leader in Sustainable Construction

Premier Graphene President Pedro Mendez Meets with Global Leader in Sustainable Construction

Aug 8, 2024

Premier’s Graphene Suspensions Receiving Interest from one of the World’s Largest Materials Handling Companies EL CENTRO, California, August 8, 2024 – Premier Graphene, Inc. (OTC PINK: BIEI) announced today that one of the world’s largest materials handling company invited Premier Graphene to permit them to test and separately confirm HGI's proprietary hemp-based graphene formulation in concrete with respect to which it has a distribution license in the United States. Impressed with the...

ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides

ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS

Aug 8, 2024

Patents issued in mainland China protect the Company’s novel secreted Klotho protein and Its gene delivery system Recent Patents issued in Hong Kong and Shanghai support protection to develop treatments for Alzheimer’s Disease and other neurodegenerative diseases New York, NY, August 8, 2024 - ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a US-based biotechnology company focused on developing cell- and gene-based treatments to affect aging and age-related diseases, announces the...

BLAQclouds, Inc. Announces Intent to Acquire ZEUS Blockchain Partners

BLAQclouds, Inc. Announces Intent to Acquire ZEUS Blockchain Partners

Aug 7, 2024

Las Vegas, NV, August 07, 2024 — BLAQclouds, Inc. (OTC: BCDS) is pleased to announce the intent to acquire the equity of ZEUS Blockchain Partners, Inc. through a SAFE Agreement. As part of this process BLAQclouds, Inc. now has a 90-day exclusive period to complete the transaction. ZEUS Blockchain Partners, Inc. has developed https://zeuschainscan.io/, a Layer 1 Ethereum Virtual Machine (EVM) chain, premiered with the ZEUS Token. The ZEUS Token has also been integrated as the settlement token...

SKYX Announces Corporate Update Call

SKYX Announces Corporate Update Call

Aug 7, 2024

Company to Provide Corporate Updates Including Second Quarter 2024 Financial Results; Conference Call to be Held on Monday, August 12, 2024 at 4:30 PM Eastern Time Miami, August 7, 2024 – SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe, and advanced as the...

Hollywood Star Cuts Expands Through Strategic Agreement With Utah Based Haircare Franchise Group

Hollywood Star Cuts Expands Through Strategic Agreement With Utah Based Haircare Franchise Group

Aug 7, 2024

Las Vegas, NV, August 7, 2024 – All American Gold Corp. (OTC: AAGC) is very excited to update the public about AAGC’s agreement with an existing Hair-Care Franchise group to join the Hollywood Star Cuts family. On August 5th, 2024, Hollywood Star Cuts entered into an agreement with a Utah based group that currently owns and operates twelve (12) full-service family hair salons. These salons are presently being operated under a multi-national franchise brand name. Representatives of the...

American Shared Hospital Services Announces Start of Patient Treatments at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico

American Shared Hospital Services Announces Start of Patient Treatments at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico

Aug 6, 2024

SAN FRANCISCO, CA, August 6, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that it has begun treating patients at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla (“A.B.”), in Puebla, Mexico, located 80 miles from Mexico City. AMS has a Joint Venture (“JV”) agreement with the principal...

REMSleep Holdings Inc. Issues Shareholder Letter

REMSleep Holdings Inc. Issues Shareholder Letter

Aug 6, 2024

Company Unveils Internal Corporate Goal of Capturing 10% of the CPAP Mask Market Within 24 Months CLEARWATER, Fla., August 6, 2024 - REMSleep Holdings, Inc. (OTCQB: RMSL), a leader in innovative sleep apnea products, published the following letter to shareholders. Dear REMSleep Shareholders and Interested Investors: Our company’s primary focus is two-fold. First, we are dedicated to providing high-quality products and experiences for CPAP therapy to support our customers and their families....

Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results

Oncocyte Announces August Investor Conferences Participation

Aug 5, 2024

IRVINE, Calif., August 5, 2024 — Oncocyte Corp. (Nasdaq: OCX), a molecular diagnostics technology company, today announced that CEO Josh Riggs and CFO Andrea James plan to participate in the following investor conferences in August: 9th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference, August 12-13, 2024. Oncocyte management plans to host meetings with investors. Sidoti Micro-Cap Virtual Conference, August 14-15, 2024. The company is scheduled to present on Wednesday, August 14,...

BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024

BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024

Aug 5, 2024

Conference Call and Webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., August 5, 2024, — BioStem Technologies, Inc. (OTC: BSEM), a leading medtech company specializing in the development, manufacture, and commercialization of placental-derived allografts for advanced wound care, announced today that it will release its second quarter 2024 financial results after the market close on Monday, August 12, 2024. The company will also host a conference call and webcast at 4:30 PM ET to discuss the...

Vocodia Holdings Announces $2.8 million Preferred Stock Purchase Agreement as part of a $3.0 million Capital Raise

Vocodia Holdings Announces $2.8 million Preferred Stock Purchase Agreement as part of a $3.0 million Capital Raise

Aug 5, 2024

Boca Raton, FL, August 5, 2024 – Vocodia Holdings Corp (CBOE: VHAI) (“Vocodia” or the "Company") a leader in AI software development focusing on practical AI applications, today announced the execution of a Securities Purchase Agreement (the “SPA”) and a Placement Agency Agreement marking a pivotal step in Vocodia’s strategic growth initiatives and capital structure optimization. Under the terms of the SPA, the Company has entered into an agreement with certain accredited investors for the...

Direct Equity Source Announces Strategic Partnership with AAA Storage to Expand Self-Storage Portfolio

Direct Equity Source Announces Strategic Partnership with AAA Storage to Expand Self-Storage Portfolio

Aug 2, 2024

Austin, Texas, August 2, 2024 – Direct Equity Source, a leading real estate private equity firm, is pleased to announce a strategic partnership with AAA Storage, an industry-leading self-storage company. Direct Equity Source, via its recently formed fund, will be the largest single investor in AAA Storage’s current multi-property Growth Fund I, and significantly expand its self-storage portfolio across the United States. This partnership combines Direct Equity Source's extensive experience in...

Vocodia Holdings Announces $2.8 million Preferred Stock Purchase Agreement as part of a $3.0 million Capital Raise

Vocodia’s Demos Offer Human-Like AI Interactions

Aug 2, 2024

Chicago, August 2, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI), a pioneering AI software company specializing in practical AI solutions, today invites the public to try out one of four groundbreaking Conversational AI demos to see how Vocodia’s Digital Intelligent Sales Agents (DISA) actually work. Vocodia’s technology platform harnessed the power of conversational AI and is changing the game for contact centers in all industries and today we are inviting you to take a closer look at DISA and...

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

Aug 1, 2024

PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 2,066,000 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $0.62 per share (or...

Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

Aug 1, 2024

Conference Call and Webcast on Thursday, August 8, 2024 at 2:00 p.m. PT / 5:00 p.m. ET IRVINE, Calif., Aug 1, 2024 - Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced today that the company will release its second quarter 2024 financial results on Thursday, August 8, 2024, after U.S. market close. The company will host a conference call and webcast on Thursday, August 8, 2024, at 5:00 p.m. Eastern Time to discuss its financial results and highlights. Interested parties...

SPZI: Bloxcross and JP3E Announce the Global Trade Financing Platform Is Live

SPZI: Bloxcross and JP3E Announce the Global Trade Financing Platform Is Live

Aug 1, 2024

NEW YORK, August 1, 2024 - JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., recently acquired a majority stake in Bloxcross, Inc. In the wake of this significant acquisition, they announce the launch of a new Global Trade Financing Platform, positioning Bloxcross as a key element of the JP3E portfolio. We expect that the Global Trade Financing Platform will make a substantial contribution to the revenue of both JP 3E Holdings and Bloxcross by executing existing commodity contracts....

Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

Aug 1, 2024

PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,066,000 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $0.62 per share (or pre-funded warrant in lieu thereof) in a registered direct offering...

PRISM MarketView Launches AI Infrastructure and Datacenter Index

PRISM MarketView Launches AI Infrastructure and Datacenter Index

Aug 1, 2024

New Index Showcases Companies Positioned to Fuel the Booming AI Market NEW YORK, August 01, 2024-- PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AI Infrastructure and Datacenter Index in response to significant global growth and interest in AI technology. The new PRISM index tracks emerging companies supplying AI-related infrastructure and the datacenters that store this technology. The global AI market...

NATURAL HARMONY FOODS INC. COMPLETES FINANCIAL AUDITS FOR 2022 & 2023

NATURAL HARMONY FOODS INC. COMPLETES FINANCIAL AUDITS FOR 2022 & 2023

Jul 31, 2024

UNLOCKING FUNDS TO ACCELERATE OPERATIONS NEW YORK, NY July 31st, 2024 - Publicly-held Natural Harmony Foods Inc. (OTC: NHYF), is delighted to report the completion of its financial statement audits for the years 2022 and 2023. This accomplishment represents a significant advancement in the Company's corporate governance and will underpin its ongoing operations. It will also assist in removing its current shell status and lay the groundwork for its desired OTCQB listing. The...

Sono-Tek Announces Largest Order in Company History

Sono-Tek Announces Largest Order in Company History

Jul 31, 2024

$2.95 Million Order from Specialty Clean Energy Customer Third Part of Expected Multi-System Program 4 System Order Expected to be Shipped in First Half of Fiscal 2026 MILTON, NY, July 31, 2024 - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, is pleased to announce that it has received a significant new order from an existing clean energy customer. The $2.95 million order is the third part of an anticipated multi-system program and is...

PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends

PRISM MarketView Examines Airline Industry Policies, Financial Reports and Consumer Trends

Jul 30, 2024

NEW YORK, NY July 30, 2024 - PRISM MarketView, a leader within the financial markets and news community, announces the release of an article highlighting the traveling consumer as airlines began to announce financial results. Company reports have echoed larger themes related to higher fuel costs, robust travel demand and lower fare discounting driven by competition from low-cost carriers. American Airlines faced a significant decline in profits due in part to an operational decision to make...

Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential

Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential

Jul 30, 2024

NEW YORK and SANTA BARBARA, Calif., July 30, 2024 - Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules, today announced the release of its new investor deck. The updated presentation provides an in-depth look at the company’s strategic vision, scientific advancements, and growth potential as it progresses towards the development of next-generation cannabinoid medicines. The...

AB INTL GROUP Announced Fencing Film “THE ONE” Premiere for Screening on Cinemas in China

AB INTL GROUP Announced Fencing Film “THE ONE” Premiere for Screening on Cinemas in China

Jul 30, 2024

NEW YORK, July 30, 2024 -- AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces its fencing film “THE ONE” (YiJianZhongQing), its distributor has executed definitive agreement with Hua Xia Film Group, the leading nationwide distributor in China to distribute the movie to be screened in cinemas nationwide beginning on 1st day of August 2024. The starring cast along with the director will attend the press conference to kick...

Greg Duffell and Peter Stockmann of Vulcain.ai Join Vocodia Holdings Corp. as Strategic Advisors

Jul 30, 2024

CHICAGO, July 30, 2024- Vocodia Holdings Corp. (CBOE: VHAI), a pioneering AI software company specializing in practical AI solutions, today announced that Greg Duffell and Peter Stockmann of Vulcain.ai join Vocodia Holdings Corp. as Strategic Advisors, bringing a wealth of global expertise that will help open doors for Vocodia. Brian Podolak, Founder and CEO of Vocodia, commented, “We are excited that Greg and Peter will be joining Vocodia as strategic advisors. Each brings with them extensive...

SKYX Announces a Collaboration with Home Depot for its Advanced and Smart Plug & Play Products for both Retail and Professional Segments

SKYX Announces a Collaboration with Home Depot for its Advanced and Smart Plug & Play Products for both Retail and Professional Segments

Jul 30, 2024

SKYX will Offer a Variety of its Advanced and Smart Plug & Play Products including Retrofit Kits, Smart Light Fixtures, Smart Ceiling Fans, Ceiling Outlet Receptacles, Recessed Lights and More Miami, FL, July 30, 2024 – SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 94 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and buildings...

AmpliTech Group’s AGTGSS Division Unveils Comprehensive Private 5G End-to-End Solution for Businesses and Homes

AmpliTech Group’s AGTGSS Division Unveils Comprehensive Private 5G End-to-End Solution for Businesses and Homes

Jul 29, 2024

Fixed 5G Wireless Access (FWA) is now a reality Hauppauge, NY, July 29, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, proudly announces the launch of its AGTGSS Division's complete Private 5G End-to-End...

Vocodia Expands into Online Education with Agreement with American High School

Jul 29, 2024

CHICAGO, July 29, 2024 - Vocodia Holdings Corp. (CBOE: VHAI), a pioneering AI software company specializing in practical AI functions, today announced an agreement with American High School, an accredited, diploma granting online high school that offers a convenient and self-paced learning experience. This agreement seeks to apply Vocodia’s conversational AI technology to help enrolled American High School students with the associated tutoring program. Vocodia’s technology will assist students...

Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients

Jul 29, 2024

Top Line Data Expected Year-End 2024 Pittsburgh, July 29, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the enrollment of the first patients in its multi-center Phase 2a clinical trial evaluating LP-310 for the treatment of Oral Lichen Planus (OLP). This chronic inflammatory condition, which affects over 6 million Americans, is characterized by...